Clinical Trial Update: HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating HDV-Interferon for chronic hepatitis C in nonresponders and naive patients. The status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HDV-Interferon

Snippet

Sponsor: Hepasome Pharmaceuticals | Conditions: Chronic Hepatitis C | Phase 2 | Status: UNKNOWN